India’s indigenously-developed COVID-19 vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients to travel abroad without mandatory quarantine, NITI Aayog’s Member, Health, VK Paul said on Wednesday, 15 September.
“Data sharing and data evaluation are going on and a positive decision may come soon. The data sharing and data evaluation have been going on through multiple reviews and we are close to a decision point,” he said.
